Skip to main content
Top
Published in: Obesity Surgery 2/2011

01-02-2011 | Clinical Research

Metabolic Syndrome after Bariatric Surgery. Results Depending on the Technique Performed

Authors: Jose Antonio Gracia-Solanas, M. Elia, V. Aguilella, J. M. Ramirez, J. Martínez, M. A. Bielsa, M. Martínez

Published in: Obesity Surgery | Issue 2/2011

Login to get access

Abstract

Background

There is a lack of long-term studies for metabolic syndrome after bariatric surgery. Our aim is to show the evolution of the parameters that define the metabolic syndrome after bariatric surgery, up to 10 years of follow-up, in order to clarify what technique gets better results with fewer complications.

Methods

The IDF definition of the metabolic syndrome was used for this study. One hundred twenty-five morbid obese and superobese patients underwent vertical banded gastroplasty. Two hundred sixty-five morbid obese and superobese patients had biliopancreatic diversion (Scopinaro and modified biliopancreatic diversions), and 152 morbid obese patients underwent laparoscopic gastric bypass. A mean follow-up of up to 7 years was done in all groups.

Results

Prior to surgery, metabolic syndrome was diagnosed in 114 patients of Scopinaro group (76%), in 85 patients of modified biliopancreatic diversion group (73.9%), in 81 patients of laparoscopic gastric bypass (53.4%), and in 98 patients of vertical banded gastroplasty (78.4%). When metabolic syndrome parameters were evaluated at 7 years of follow-up, owing to weight gain, these results changed nearby to preoperative values in both laparoscopic gastric bypass and vertical banded gastroplasty groups.

Conclusion

According to our results, the best technique to resolve metabolic syndrome is the modified biliopancreatic diversion. Due to its high morbidity, it only must be considered in superobese patients. In obese patients, the laparoscopic gastric bypass may be a less agressive choice, but it should be coupled with lifestyle changes to keep away from the weight gain in the long run. Restrictive procedures may be indicated only in a few well-selected cases.
Literature
1.
go back to reference Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287:356–9.CrossRefPubMed Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287:356–9.CrossRefPubMed
2.
go back to reference Grupo de trabajo resistencia a la insulina de la Sociedad Española de Diabetes. Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a diabetes tipo 2. Med Clin (Barc) 2002;119:458–63. Grupo de trabajo resistencia a la insulina de la Sociedad Española de Diabetes. Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a diabetes tipo 2. Med Clin (Barc) 2002;119:458–63.
3.
go back to reference Adams T, Gress R, Smith S, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.CrossRefPubMed Adams T, Gress R, Smith S, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.CrossRefPubMed
4.
go back to reference Zimmet P, Alberti K, Serrano M. Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol. 2005;58:1371–6.CrossRefPubMed Zimmet P, Alberti K, Serrano M. Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol. 2005;58:1371–6.CrossRefPubMed
5.
go back to reference Picot J, Jones J, Colquit JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215–357. Picot J, Jones J, Colquit JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215–357.
6.
go back to reference Gracia JA, Martinez M, Elia M, et al. Obesity surgery results depending on technique performed. Long-term outcome. Obes Surg. 2009;19:432–8.CrossRefPubMed Gracia JA, Martinez M, Elia M, et al. Obesity surgery results depending on technique performed. Long-term outcome. Obes Surg. 2009;19:432–8.CrossRefPubMed
7.
go back to reference Scopinaro N, Papadia F, Camerini G, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18:1035–8.CrossRefPubMed Scopinaro N, Papadia F, Camerini G, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18:1035–8.CrossRefPubMed
8.
go back to reference Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554–9.CrossRefPubMed Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554–9.CrossRefPubMed
9.
go back to reference Sanchez-Cabezudo C, Díaz-Guerra C, Larrad Jiménez A. Analysis of weight loss with biliopancreatic diversion of Larrad: absolute failures or relative successes. Obes Surg. 2002;12:249–52.CrossRef Sanchez-Cabezudo C, Díaz-Guerra C, Larrad Jiménez A. Analysis of weight loss with biliopancreatic diversion of Larrad: absolute failures or relative successes. Obes Surg. 2002;12:249–52.CrossRef
10.
go back to reference Rubio MA, Moreno C. Tratamiento médico de la obesidad mórbida: alternativas actuales, límites y perspectivas. Cir Esp. 2004;75:219–24. Rubio MA, Moreno C. Tratamiento médico de la obesidad mórbida: alternativas actuales, límites y perspectivas. Cir Esp. 2004;75:219–24.
11.
go back to reference Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg. 1998;8(5):487–99.CrossRefPubMed Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg. 1998;8(5):487–99.CrossRefPubMed
12.
go back to reference Weiss R, Appelbaum L, Schweiger C, et al. Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery. Diab Care. 2009;32:1910–5.CrossRef Weiss R, Appelbaum L, Schweiger C, et al. Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery. Diab Care. 2009;32:1910–5.CrossRef
13.
go back to reference Pontiroli AE, Laneri M, Veronelli A, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol. 2009;20:37.CrossRef Pontiroli AE, Laneri M, Veronelli A, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol. 2009;20:37.CrossRef
14.
go back to reference Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. A systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. A systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed
15.
go back to reference Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diab Care. 2001;24:362–5.CrossRef Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diab Care. 2001;24:362–5.CrossRef
16.
go back to reference Mannucci E, Monami M, Rotellac M. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study. Nutr Metab Cardiovasc Dis. 2007;17:719–26.CrossRefPubMed Mannucci E, Monami M, Rotellac M. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study. Nutr Metab Cardiovasc Dis. 2007;17:719–26.CrossRefPubMed
17.
go back to reference Estheghamati A, Zandieh A, Khalilzadeh O, et al. Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetol Metab Syndr. 2010;2:36.CrossRef Estheghamati A, Zandieh A, Khalilzadeh O, et al. Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetol Metab Syndr. 2010;2:36.CrossRef
18.
go back to reference Harvey A, Blackburn G, Apovian C, et al. Lehman Center Weight Loss Surgery Expert Panel. Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction. Expert Panel on Weight Loss Surgery: executive report. Obes Res. 2005;13:205–26.CrossRef Harvey A, Blackburn G, Apovian C, et al. Lehman Center Weight Loss Surgery Expert Panel. Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction. Expert Panel on Weight Loss Surgery: executive report. Obes Res. 2005;13:205–26.CrossRef
19.
go back to reference Pekka T, Victorzon M, Mäkelä J. 11-year experience with laparoscopic adjustable gastric banding for morbid obesity—what happened to the first 123 patients? Obes Surg. 2008;18:251–5.CrossRef Pekka T, Victorzon M, Mäkelä J. 11-year experience with laparoscopic adjustable gastric banding for morbid obesity—what happened to the first 123 patients? Obes Surg. 2008;18:251–5.CrossRef
20.
go back to reference del Amo Arribas D, Elia Guedea M, Aguilella Diago V, et al. Effect of vertical banded gastroplasty on hypertension, diabetes and dyslipidemia. Obes Surg. 2002;12:319–23.CrossRef del Amo Arribas D, Elia Guedea M, Aguilella Diago V, et al. Effect of vertical banded gastroplasty on hypertension, diabetes and dyslipidemia. Obes Surg. 2002;12:319–23.CrossRef
21.
go back to reference NIH Conference. Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med. 1991;115:956–61. NIH Conference. Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med. 1991;115:956–61.
22.
go back to reference Recomendaciones de la SECO para la práctica de la cirugía bariátrica (Declaración de Salamanca). Cir Esp. 2004;75:312–4. Recomendaciones de la SECO para la práctica de la cirugía bariátrica (Declaración de Salamanca). Cir Esp. 2004;75:312–4.
23.
go back to reference Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19:577–82.CrossRefPubMed Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19:577–82.CrossRefPubMed
24.
go back to reference Christou NV, Look D, MacLean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734–40.CrossRefPubMed Christou NV, Look D, MacLean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734–40.CrossRefPubMed
25.
go back to reference Feldstein AC, Nichols GA, Smith DH, et al. Weight change in diabetes and glycemic and blood pressure control. Diab Care. 2008;31:1960–5.CrossRef Feldstein AC, Nichols GA, Smith DH, et al. Weight change in diabetes and glycemic and blood pressure control. Diab Care. 2008;31:1960–5.CrossRef
26.
go back to reference Batsis JA, Romero-Corral A, Collazo-Clavell MI, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83:897–907.CrossRefPubMed Batsis JA, Romero-Corral A, Collazo-Clavell MI, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83:897–907.CrossRefPubMed
27.
go back to reference Ocón Bretón J, García B, Benito P, et al. Effect of gastric bypass on the metabolic syndrome and on cardiovascular risk. Nutr Hosp. 2010;25:67–71.PubMed Ocón Bretón J, García B, Benito P, et al. Effect of gastric bypass on the metabolic syndrome and on cardiovascular risk. Nutr Hosp. 2010;25:67–71.PubMed
28.
go back to reference Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA. 2008;299:316–23.CrossRefPubMed Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA. 2008;299:316–23.CrossRefPubMed
30.
go back to reference Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21–35.CrossRefPubMed Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21–35.CrossRefPubMed
31.
go back to reference Klein S, Lora K, Burke RN, et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Circulation. 2004;110:2952–67.CrossRefPubMed Klein S, Lora K, Burke RN, et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Circulation. 2004;110:2952–67.CrossRefPubMed
Metadata
Title
Metabolic Syndrome after Bariatric Surgery. Results Depending on the Technique Performed
Authors
Jose Antonio Gracia-Solanas
M. Elia
V. Aguilella
J. M. Ramirez
J. Martínez
M. A. Bielsa
M. Martínez
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 2/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0309-6

Other articles of this Issue 2/2011

Obesity Surgery 2/2011 Go to the issue